CLINICAL USES
MYOHEM is a scientifically formulated herbal supplement designed to support cardiovascular health. Its key ingredients, Terminalia Arjuna and Rauwolfia Serpentina, have been clinically studied for their anti-ischemic, antioxidant, and heart-strengthening properties. This natural remedy helps improve blood circulation, regulate blood pressure, and reduce cholesterol levels, making it beneficial for individuals with hypertension, angina, and other heart-related conditions. Regular use promotes overall heart wellness without harmful side effects.
Angina/myocardial infarction
The anti-ischemic effect caused significant decrease in systolic blood pressure (SBP), improvement in ECG changes, and reduction in plasma cortisol and serum cholesterol levels.
CHF/hypertension
The researchers observed improvement in the functional class, breathlessness, and overall well-being with significant diuresis, and a fall in both systolic and diastolic blood pressure
Rheumatic heart disease
The results revealed a significant improvement in LVEF, exercise duration, and significant reduction in heart size.
Ischemic mitral regurgitation
significantly decrease IMR and anginal frequency. In addition, there was also significant improvement in diastolic dysfunction
Cardiomyopathy
arjuna was found to reduce LVM and improve LVEF. there was a significant improvement in left ventricular parameters as well as functional capacity.
Platelet aggregation
The bark extract has been found to decrease platelet activation and possess antithrombotic properties. It also caused significant inhibition of platelet aggregation.
Oxidative stress/dyslipidaemia
improvement in lipid profile. significant decrease in TC, LDL, and lipid peroxide levels. A significant reduction in TC, LDL, TG, serum C-reactive protein, blood glucose, and an increase in HDL level were found, which supported the role of arjuna in dyslipidemic patients.
Lipoprotein(a)
A significant reduction in lipoprotein(a) levels
Endothelial dysfunction
improvement in lipid profile. significant decrease in TC, LDL, and lipid peroxide levels. A significant reduction in TC, LDL, TG, serum C-reactive protein, blood glucose, and an increase in HDL level were found, which supported the role of arjuna in dyslipidemic patients.
Thrombotic condition
In a recent study in vitro thrombolytic and membrane-stabilizing action, the methanol extract was found to possess significant thrombolytic activity (30.57%). It also significantly inhibited the homolysis of RBCs in both hypotonic solution and heat-induced conditions. This showed that it has moderate thrombolytic activity; Results from a recent in vitro study indicate that arjuna extracts contain constituents that can potently inhibit the activity of CYP1A.